Source:http://linkedlifedata.com/resource/pubmed/id/12451010
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-11-26
|
| pubmed:abstractText |
Previous studies suggested that blockade of RAGE in diabetic apolipoprotein (apo) E-null mice suppressed early acceleration of atherosclerosis. A critical test of the potential applicability of RAGE blockade to clinical settings was its ability to impact established vascular disease. In this study, we tested the hypothesis that RAGE contributed to lesion progression in established atherosclerosis in diabetic apoE-null mice.
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:citationSubset |
AIM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:author |
pubmed-author:BucciarelliLoredana GLG,
pubmed-author:GoovaMouza TMT,
pubmed-author:KAYL MLM,
pubmed-author:KashyapYogitaY,
pubmed-author:KislingerThomasT,
pubmed-author:LallaEvanthiaE,
pubmed-author:LeeDaniel CDC,
pubmed-author:MoserBernhardB,
pubmed-author:RongLing LingLL,
pubmed-author:SchmidtAnn MarieAM,
pubmed-author:SternDavid MDM,
pubmed-author:WendtThoralfT,
pubmed-author:WinSS
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
2827-35
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:articleTitle |
RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice.
|
| pubmed:affiliation |
Division of Surgical Science, College of Physicians & Surgeons, Department of Surgery, Columbia University, New York, NY 10032, USA.
|